Naseem Zojwalla is CHIEF MEDICAL OFFICER of Olema Pharmaceuticals, Inc.. Currently has a direct ownership of 89,824 shares of OLMA, which is worth approximately $989,860. The most recent transaction as insider was on May 24, 2024, when has been sold 9,460 shares (Common Stock) at a price of $4.87 per share, resulting in proceeds of $46,070. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 89.8K
11.77% 3M change
n/a 12M change
Total Value Held $989,860

Naseem Zojwalla Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 24 2024
BUY
Exercise of conversion of derivative security
$46,070 $4.87 p/Share
9,460 Added 9.53%
89,824 Common Stock
Mar 18 2024
BUY
Exercise of conversion of derivative security
$66,719 $4.87 p/Share
13,700 Added 14.56%
80,364 Common Stock
Jan 25 2024
BUY
Exercise of conversion of derivative security
$140,400 $7.02 p/Share
20,000 Added 23.08%
66,664 Common Stock
Dec 11 2023
BUY
Exercise of conversion of derivative security
$20,358 $7.02 p/Share
2,900 Added 5.85%
46,664 Common Stock
Dec 06 2023
BUY
Exercise of conversion of derivative security
$91,962 $7.02 p/Share
13,100 Added 23.04%
43,764 Common Stock
Nov 22 2023
SELL
Open market or private sale
$98,549 $13.89 p/Share
7,095 Reduced 18.79%
30,664 Common Stock
Nov 21 2023
SELL
Open market or private sale
$112,511 $15.08 p/Share
7,461 Reduced 16.5%
37,759 Common Stock
Nov 20 2023
BUY
Grant, award, or other acquisition
-
28,000 Added 38.24%
45,220 Common Stock
NZ

Naseem Zojwalla

CHIEF MEDICAL OFFICER
San Francisco, CA

Track Institutional and Insider Activities on OLMA

Follow Olema Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OLMA shares.

Notify only if

Insider Trading

Get notified when an Olema Pharmaceuticals, Inc. insider buys or sells OLMA shares.

Notify only if

News

Receive news related to Olema Pharmaceuticals, Inc.

Track Activities on OLMA